Leflunomide ELVIM

Medicinal product

(Invented) name

Leflunomide ELVIM

Active substance (s)

Leflunomidas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AK01, Leflunomide

Marketing authorisation holder

SIA ELVIM, Latvija

Date of authorisation

2023-05-12

Date of renewal

Documents

Leflunomide Elvim mokomoji medziaga sveikatos prieziuros specialistams.pdf

Leflunomide Elvim mokomoji medziaga pacientams.pdf

5181-5182_pakuotes lapelis_2023-05-12.docx

5181-5182_Leflunomide ELVIM.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LV/H/0230/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Leflunomidas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110991	97102	1097102	lizdinė plokštelė	N30		Receptinis	LT/1/23/5182/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-05-12	Registruotas